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-a letter detailing your responses to the referee comments in Word format (.doc) -a Microsoft Word file (.doc) of the revised manuscript text -editable TIFF or EPS-formatted figure files in high resolution. In order to avoid delays later in the process, please read our figure guidelines before preparing your manuscript figures at: http://www.embopress.org/sites/default/files/EMBOPress_Figure_Guidelines_061115.pdf
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As part of the EMBO publication's Transparent Editorial Process, EMBO reports publishes online a Review Process File (RPF) to accompany accepted manuscripts. This File will be published in conjunction with your paper and will include the referee reports, your point-by-point response and all pertinent correspondence relating to the manuscript.
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REFEREE REPORTS

Referee #1:
This manuscript by Yang and colleagues demonstrates the use of a reporter strain for the endogenous retrovirus MERVL for assessing the efficiency of somatic cell nuclear transfer. They demonstrate clearly that this reporter can faithfully recapitulate zygotic genome activation events. In this respect the manuscript is original. The authors use this model to demonstrate an important role for H3K27me3 reprogramming during somatic cell nuclear transfer in the mouse, in particular in relation to enabling zygotic genome activation. With respect to the role of H3K27me3 in reprogramming this has been demonstrated before in a previous publication, which the authors fail to cite; Bai et al., Zygote 2018, 'Kdm6a overexpression improves the development of cloned mouse embryos'. However the current manuscript goes beyond the former by demonstrating a role for K27me3 reprogramming in zygotic genome activation, by performing correlative RNA sequencing and live imaging experiments and by demonstrating an increase in full-term potential with KDM6B knockdown. Therefore I believe that this manuscript meets the required standards in terms of originality and broad application to the fields of developmental biology, epigenetics and reprogramming. In general I am of the opinion that the conclusions drawn are well-founded, as the data is clearly presented, appropriate controls are present and interpretations are suitable. Overall I would recommend this manuscript for publication in EMBO Reports. However there are a number of (mostly minor) problems with the current manuscript, which I feel that if correct, would improve the presentation and accessibility of the manuscript. I have highlighted the most important criticisms with a *, mostly relating to the validation of the reporter and the findings regarding histone methylation in Figure 3 . Figure 1 Page 6, line 131, the authors should provide the references for the somatic genes reported to inhibit reprogramming. *Can the authors show that the reporter faithfully recapitulates the expression of the endogenous MERVL? They present data showing that it is expressed at the 2-cell stage correctly, but don't show the lack of expression at later stages as they show in Figure 1D . This data needs to be presented. * Figure 1E . The changes in gene expression are always normalized to Gapdh only. Are the levels of Gapdh constant between tdTomato-and tdTomato+? As the experiments uses a defined number of cells (20 embryos) normalization is not required. Do the authors see similar differences in the 6 genes between Tomato -and Tomato+ on absolute levels of expression? Figure 1G . It would be helpful to present a timecourse of embryonic development (as in Figure 5E ) for Tomato-and + ICSI and SCNT embryos, to make the results clearer to the reader.
Figure 2
Figures F and G are either mislabeled in the legends or the y-axes of the graphs are incorrectly annotated. It is therefore difficult from the current version to understand the difference in blastocyst quality between SCNT Tomato-/+. In relation to this it would also be useful to present immunostainings of key lineage markers for ICM, EPI, PE and TE in blastocysts from SCNT Tomato-and + conditions, such as Oct4, Cdx2, Nanog and Gata4 to determine if blastocyst lineage segregation occurs correctly or not. *It appears from Figure 2B and Movie 1 that MERVL-Tomato reporter expression is maintained in some blastocysts. This is apparently in contradiction to Figure 1D . Can the authors explain this discrepancy? This is important because it suggests that this reporter does not faithfully recapitulate the endogenous pattern of expression of MERVL. Figure 3A The difference in H3K27me3 staining between Tomato-/+ is dramatic. However, it is surprising that H3K27me3 is undetectable in ICSI embryos, considering that naturally fertilised embryos have significant levels of H3K27me3 at the 2-cell stage (Jachowicz et al., Genes Dev. 2013). Are the low levels due to ICSI? This also applies to the paternal pronucleus in Figure 3B , for naturally fertilized embryos a clear K27me3 staining around the NLBs is present (see Puschendorf et al., Nat Genet 2008).If the authors show increased intensity images, can they now see the expected K27me3 distriubtion at the 2-cell stage and paternal pronucleus in the zygote? Figure 3B The image of syngamy is unclear as it appears to show just one nucleus. Can the authors show individual z-sections of the maternal and paternal pronuclei to demonstrate more clearly the asymmetric pattern of H3K27me3? * Figure 3D . H3K27me3 staining now clearly appears in the 4-cell stage with no apparent difference between Tomato-and + groups. This is apparently at odds with the dramatic difference between these two groups at the 2-cell stage. How do the authors explain this dramatic change from the 2-cell to 4-cell stage? *In addition the difference the authors report at the morula stage is not well-founded as the image presented for the Tomato-group is not in fact a morula, as it contains significantly more cells than the other groups. It is essential to compare similar stages of development. * Figure 3F . Is this method of quantification a fair representation of the data? Dividing embryos into positive and negative groups necessitates a clear bimodal pattern of staining between negative and positive groups. Can the authors show that this is indeed the case? Otherwise a quantification of average fluorescence intensity in nuclei is required. Figure 4 appears sound scientifically, although the presentation needs improvement. What is being shown in Figure 4C ? Is it a digestion of the vector? Or an RNA gel of the transcribed product? The text needs improvement also, as for example page 8, line 183; 'the KDM6A and KDM6B expression vectors specifically demethylate H3K27me3'. The vectors do not demethylate. Page 7, line 177 the HA tag is in the wrong orientation -it should be KDM6A-HA for a C-terminal tag. Perhaps the title of Figure 4 could be changed to include '...but not full-term development'. Figure 5 is also scientifically convincing. However it would be interesting to determine if the effect of KDM6B knockdown on embryonic development and later zygotic genome activation is dependent on the observed increase in levels of KDM6A as the authors suggest. *In this regard a double knockdown of both KDM6A and KDM6B should prevent the beneficial effects of KDM6B single knockdown.
Figure 5B The authors suggest that the optimal injection concentration was 10uM (page 9, line 217). In Figure 5B it appears that the 20uM concentration is more efficient at reducing levels of KDM6B. What are the other reasons for the choice of 10uM? Is 20uM detrimental for development? Figure 6D . What is represented by the red spots? Figure 6G Are the y-axes of the bar graphs annotated correctly? Page 11, line 272 "As expected, si6B-mdx-ntES expression of ESCs markers.' is not a grammatically correct sentence. Page 11, line 284, LINE-1 is not an ERV.
* Figure 7A , as for Figure 1E , the authors should also show absolute expression values without normalization to Gapdh. It is possible that Gapdh is also affected by KDM6B downregulation. Page 12, line 300. Should refer to Extended Figure 7C not Figure 7C .
Referee #2:
Yang et al. performed a following up study on investigating the role of H3K27me3 demethylases in mouse cloned embryos. They reported that the low efficiency of cloned embryos is due to the H3K27me3 reprogramming barrier. By manipulation of the level of demethylases of H3K27me3 (Overexpression of Kdm6a and knockdown of Kdm6b), the authors claim that they can improve the reprogramming efficiency. However, there are some major comments that I can't be convinced by this conclusion.
Major comments:
Novelty: This study is mainly based on the authors' previous finding in Sci Reports (Yang et al., 2016) . The title of this manuscript is very similar to previous one. Also, the main hypothesis (compensation of Kdm6a and Kdm6b) is based on the previous finding. Therefore, the authors didn't characterise well enough their observation on the level of H3K27me3 in cloned embryos.
Firstly, the authors claim that the complete loss of H3K27me3 in ICSI and upregulated of H3K27me3 in cloned embryos. The conclusion is inconsistent with a few previous papers (e.g in Zhang et al., 2009 JBC and Bao et al., 2005 EMBO Reports, the level of H3K27me3 were both datable in control and cloned embryos). Do the level of increasing H3K27me3 due to the changes of the level of H3K27me2? The authors claim that H3K27me3 is the only histone markers changed in cloned 2-cells. However, in my eyes, I saw a stronger intensity of H3K9me3 and a weaker level of H3K4me3 in SCNT tdTomato+ 2-cell (FigS3A). The number of scanned embryos is very low (n was less than 5 ) and there was no quantification. I suggest the authors should provide convincing statistical analyses on all of their key IF results (Fig2D, 3A 4E S3A S6D etc.). Otherwise, I am hesitating to believe those representative images.
In the authors' previous paper in Sci Reports, they claimed that there was no difference of H3K27me3 level in Kdm6a and Kdm6b knockdown parthenogenetic embryos. And knockdown of Kdm6b induced upregulation of Kdm6a. Based on their previous report, hence, the authors didn't check the level of H3K27me3 in the main Kdm6b knockdown experiments. If the level of H3K27me3 remains unchanged in Kdm6b siRNAs KD as their previous study, the overall conclusion could be wrong.
Does any full-term pup been born in control cloned group?
It is known that H3K27me3 expresses in early embryos, disappears in morula and re-expresses in blastocysts. Do the authors' approaches (over expression of Kdm6a and knockdown of Kdm6b) alter and rescue the level of H3K27me3 in cloned morula and blastocysts (Fig5A-B)? Does artificial manipulation the level of H3K27me3 result in improvement of the developmental rate only during pre-implantation but not in full-term rate? The authors are interested in understanding more about the differences between SCNT embryos and normal blastocysts. There has been prior work in this field, exploring the differences in transcription and chromatin factors, including some overlap with work present in this manuscript. However, our understanding is far from complete, and of high general interest -both for understanding this important early phase of development and for understanding how we might improve SCNT in mice and other mammals. The work is generally well designed and executed, and this paper has some novel work of interest, but the extent of novelty is not clear due to a recent publication by GY Bai et al., in Zygote (Cambridge Press) https://doi.org/10.1017/S0967199417000673 I think the reviewers and/or editor need to examine this new paper in detail (not available by open access) to determine the novelty of this paper.
The current work contains a set of major claims: 1) Most SCNT embryos have ZGA failure and arrest at the 2-cell stage. This is well shown, but already published by Matoba, et 2) A mouse with a MervL-tdTomato reporter is made, and SCNT blastocysts implant but don't develop after implantation. 3) SCNT embryos have more K27me3 than they should at 2-cell stage. 4) siRNA KD of KDM6B increases Kdm6A, and improves blastocyst formation and embryo birth rate. 5) Overexpression of KDM6A (but not KDM6b) improves preimplantation development, but postimplantation is still defective. 6) RNA-seq analysis shows that KDM6b KD is similar to fertilized embryos.
Major Issues: 1. I was not able to download and read the GY Bai et al., paper in Zygote (Dec 2017 online, Feb. 2018 published in print). The abstract indicates considerable overlap in the major claims. The editor should obtain this and consider the overlap, or relay to the reviewers for consideration. 2. Considering the Inoue, et al. G&D 2017, is the impact on improved preimplantation mainly mediated through XIST? Did they analyze this transcript in Fig. 7 ? 3. Are the mouse lines with MERLV-tdTomato reporter isogenic? Do the authors know how many copies of the transgenes exist in the genome? These details should be included in the methods section. 4. Are the SCNT-Mervl-tdTomato blastocysts that implant but don't survive actually parthenotes?
Issues of interest that could be clarified: 1. What is the difference in domain structure between KDM6A and KDM6B? Is this effect dependent on catalytic effect? Could this be added to the discussion? Future experiments could test whether chimera proteins from KDM6A/B could identify the critical regions required for these effects. 2. Do female embryos produced through KDM6B KD or KDM6A overexpression exhibit normal Xinactivation? For instance, immunostaining with H3K27me3 antibodies should be able to detect the Barr body in somatic tissues of XX females. Is this the case? 3. Both XY male and XX female SCNT embryos have aberrant activation of Xist (Inoue, et al. Science 2010) , and this is consistent with SCNT using male or female MEFs, Sertoli, or cumulus cells being more successful with KDM6B KD (shown in fig 5E) . Are there male XIST KO MEFs? Could the authors use these cells and test if the effect of KDM6B KD is mainly at the level or XIST expression?
cross-comments from referee 2:
Since all 3 reviewers and editor consider the novelty of this manuscript could be an issue, I believe most of the future reads will think about the same thing. The MERLV reporter mice will be very useful but I agree with referee 3's point that more information needs to be provided.
Cross-comments from referee 1:
A more in depth characterisation of the reporter strain to show that it does indeed fully recapitulate the endogenous MERVL expression pattern throughout preimplantation development is necessary (RE comments to Figures 1+2). As I mention in my review I believe that this manuscript potentially significantly extends on previous studies, and thus the novelty is not a major concern, as long as the major comments are addressed. In particular there are concerns about the H3K27me3 immunostaining experiments also from Reviewer 2. Response to Referee #1: 【In order to conveniently answer your comments, we divide them in order.】 This manuscript by Yang and colleagues demonstrates the use of a reporter strain for the endogenous retrovirus MERVL for assessing the efficiency of somatic cell nuclear transfer. They demonstrate clearly that this reporter can faithfully recapitulate zygotic genome activation events. In this respect the manuscript is original. The authors use this model to demonstrate an important role for H3K27me3 reprogramming during somatic cell nuclear transfer in the mouse, in particular in relation to enabling zygotic genome activation. With respect to the role of H3K27me3 in reprogramming this has been demonstrated before in a previous publication, which the authors fail to cite; Bai et al., Zygote 2018, 'Kdm6a overexpression improves the development of cloned mouse embryos'. However the current manuscript goes beyond the former by demonstrating a role for K27me3 reprogramming in zygotic genome activation, by performing correlative RNA sequencing and live imaging experiments and by demonstrating an increase in full-term potential with KDM6B knockdown. Therefore I believe that this manuscript meets the required standards in terms of originality and broad application to the fields of developmental biology, epigenetics and reprogramming. In general I am of the opinion that the conclusions drawn are well-founded, as the data is clearly presented, appropriate controls are present and interpretations are suitable. Overall I would recommend this manuscript for publication in EMBO Reports. However there are a number of (mostly minor) problems with the current manuscript, which I feel that if correct, would improve the presentation and accessibility of the manuscript. I have highlighted the most important criticisms with a *, mostly relating to the validation of the reporter and the findings regarding histone methylation in Figure 3 .
Response:
We really appreciate your valuable and positive comments on our manuscript. In addition, we cited and discussed Bai et al. study in our revised manuscript, and discussed this paper in Discussion section.
Comment 1: Figure 1 Page 6, line 131, the authors should provide the references for the somatic genes reported to inhibit reprogramming.
Response 1:
We would like to thank the reviewer for the detailed review of our manuscript. We have cited the related studies in the revised manuscript. Widespread expression of somatic genes was observed in inappropriate cell types in SCNT embryos, limiting their reprogramming capacity. Our focusedon donor-cell-specific genes encoding catalytically active or regulatory proteins based on their important roles in cellular function, and selected Hmga2, Nfix, Prkg2, Prrx1, and Tgfb3 (response Fig 1) . Furthermore, these somatic genes have been investigated and their removal has been utilized to improve reprogramming efficiency and to increase the viability of SCNT embryos [1] [2] [3] [4] [5] (PMID: 21898684, 28739047, 12606377, 24273450, 18066050). Comment 2: *Can the authors show that the reporter faithfully recapitulates the expression of the endogenous MERVL? They present data showing that it is expressed at the 2-cell stage correctly, but don't show the lack of expression at later stages as they show in Figure 1D . This data needs to be presented.
Response 2:
We agree with the reviewer's comments and appreciate the suggestion regarding MERVL::tdTomato expression pattern. The zygotic genome activation (ZGA) is the first major developmental transition that occurs following fertilization [6] (PMID: 20179092). The active transcription of endogenous retroviruses (ERVs) has been described during cleavage stage, yet little is known about their function and temporal regulation [7, 8] Fig 2F; in the revised version Appendix Fig S1B) . As the reviewer pointed out, in original Movie EV1 the MERVL::Tomato reporter expression is maintained in some blastocysts. This is an important point that we had overlooked. We have now performed additional live-cell imaging analysis as suggested by the reviewers. In the original live-cell image experiments, owing to we don't know the MERVL expression pattern. We used the mercury-arc-lamp illumination for the fluorescence excitation. As you know, the mercury-arc-lamp illumination provides higher-power, broad-spectrum fluorescence excitation from 370~700 nm. The over-excitation the fluorophore will lead to a quantitative detection error. In the new living-cell image experiments, we use laser lightsource to substitute the ultraviolet lamp-source. The new Images were acquired in one red fluorescence, and the power settings of the 561 nm lasers (CVI Melles Griot, Albuquerque) fired from the tip of lens were set at 0.1 mW using an optical power meter (TB-200, Yokogawa Electric). Together, these protein level results further supported that the exogenous MERVL::tdTomato reporter can capture endogenous MERVL expression in mouse early embryonic development. genes between Tomato -and Tomato+ on absolute levels of expression?
Response 3:
As the reviewer pointed out, the internal control gene should be expressed at a constant level among different experimental conditions and at all stages of development. Thus, the internal control genes, also known as reference genes, are often used housekeeping genes. The most of standardizations are done to reference genes such as 18S rRNA Method [19, 20] (PMID: 11328886, 11846609). Normalized to one or two housekeeping gene, the fold change in the target genes are in line with our previous studies.
Although we used a defined number of cells (20 embryos), but several variables need to be controlled for in gene-expression analysis. For instance, RNA quality and enzymatic efficiency between the samples. Only under the conditions of reproducible extraction of good-quality RNA, the gene transcript number is ideally standardized to the number of cells. In our present experiments, total RNA was isolated from pools of 20 embryos per assay and for each examined developmental stage. Because of the very small cell numbers used for RNA extraction, the RNA quantity could not be accurately measured by the BioPhotometer (Leuven, Eppendorf) or the Nanodrop spectrophotometer (Thermo). Normalization against internal control genes is most frequently used, because it can control all variables. As you have pointed out, the RNA quality and quantity are critical for successful gene expression analysis. Furthermore, it is not necessary to know the absolute amount of the measured mRNA (number of molecules in a sample). Because the absolute quantification using the standard curve, we need to construct the plasmid DNA or in vitro transcribed RNA, corresponding to the different target gene. This will be a big project (nearly 20 plasmids, and re-collection of ICSI-/SCNT-embryos). We used the relative mRNA quantification is enough to determining the amount of target mRNA in samples relative each to other. Figure 1G . It would be helpful to present a timecourse of embryonic development (as in Figure 5E ) for Tomato-and + ICSI and SCNT embryos, to make the results clearer to the reader.
Response 4:
Thanks for this advice. According to your suggestion we added the time-course of embryonic development for tdTomato -and tdTomato + ICSI-/SCNT-embryos (response Fig. 4 ; the revised version Fig 1I) . We also added the source data in the Appendix Table S1 . Figures F and G are either mislabeled in the legends or the y-axes of the graphs are incorrectly annotated. It is therefore difficult from the current version to understand the difference in blastocyst quality between SCNT Tomato-/+. In relation to this it would also be useful to present immunostainings of key lineage markers for ICM, EPI, PE and TE in blastocysts from SCNT Tomato-and + conditions, such as Oct4, Cdx2, Nanog and Gata4 to determine if blastocyst lineage segregation occurs correctly or not.
Response 5:
The reviewer raised a very good point. Embryonic pre-implantation development involves two lineage specifications, the blastocyst is a structure formed in the early development. The blastocyst possesses an inner cell mass (ICM) which subsequently forms the embryo of mammals, and the outer layer of the blastocyst consists of cells collectively called the trophectoderm (TE). The TE gives rise to the placenta. Previous studies have demonstrated that TE and ICM lineage segregation is controlled by a small group of transcription factors. Specifically, Cdx2 is required for TE development, while the pluripotency marker Nanog is involved in establishing the ICM fate. According to your suggestion, the blastocysts derived from SCNT were subjected to immunofluorescence staining of Nanog and Cdx2 (response Fig. 5 ; the revised version Fig 2E) . In the SCNT-tdTomato + blastocysts, Nanog and Cdx2 were exclusively localized to the nuclei of the ICM and TE, as previously reported in normal embryos [21] (PMID: 26142281). By contrast, the Nanog and Cdx2 were localized to the cytoplasm of the ICM and TE in the SCNT derived tdTomato -blastocysts. Thus, the Nanog and Cdx2 in SCNT-tdTomato -embryos are mislocalization in a spatiotemporal manner, which may partially explain the developmental defects of SCNTtdTomato -embryos. Immunofluorescence images of tdTomato + and tdTomato -blastocysts derived from SCNT. Nanog (ICM) and Cdx2 (TE) were used as lineage markers. Representative images from ≥ 55 embryos analyzed in four independent micromanipulations are shown. Scale bar, 50 µm. Comment 6: *It appears from Figure 2B and Movie 1 that MERVL-Tomato reporter expression is maintained in some blastocysts. This is apparently in contradiction to Figure 1D . Can the authors explain this discrepancy? This is important because it suggests that this reporter does not faithfully recapitulate the endogenous pattern of expression of MERVL. Figure 3A The difference in H3K27me3 staining between Tomato-/+ is dramatic. However, it is surprising that H3K27me3 is undetectable in ICSI embryos, considering that naturally fertilised embryos have significant levels of H3K27me3 at the 2-cell stage (Jachowicz et al., Genes Dev. 2013). Are the low levels due to ICSI? This also applies to the paternal pronucleus in Figure 3B , for naturally fertilized embryos a clear K27me3 staining around the NLBs is present (see Puschendorf et al., Nat Genet 2008). If the authors show increased intensity images, can they now see the expected K27me3 distriubtion at the 2-cell stage and paternal pronucleus in the zygote?
Response 7:
We deeply appreciate this truly constructive comment. We considered this point previously by Dotblot assay. The specificity of H3K27me3, H3K27me2, H3K9me3 and H3K4me3 antibodies was evaluated. The 1 ug of di-/tri-methylated lys27/ lys9/ lys27 modified biotinylated histone H3 peptides were spotted on a nitrocellulose membrane and hybridized with specific antibodies as described for western-blot analysis (response Fig. 6A ; the revised version Appendix Fig S3B) . To further confirming the antibody specificity, we performed peptide-blocking assay. Incubate affinity antibodies with the relate peptide prior to running immunofluorescence assay to see if this eliminates fluorescence against the target protein (response Fig. 6B ; the revised version Appendix Fig S3C) . Through the above results, we could conclude that the antibodies used by us have highly specificity.
Through careful analysis, we got to the root for the difference. For adjusting the microscope parameters. First, we used a sample which only incubated with the secondary antibody(ies), this would reveal the non-specific binding of the secondary antibody to the specimen. Second, the microscope parameters are set so that no signal is recorded during image acquisition of this control. This setting is used as a threshold for subsequent acquisitions to exclude false-positive signals by the secondary antibody. Next, we analyze the samples which were incubated with the specific antibody. Thus, the fluorescence signal should be detectable which is above the negative control of the secondary antibody (Normal exposure). According to the reviewer's helpful suggestion, we increase the intensity of the laser (Elevated exposure). In the Elevated exposure condition, we found a faint H3K27me3 signal in the 2-cell SCNT-tdTomato + and ICSI-embryos (response Fig. 6C , D; the revised version Fig 3A, B) . To further consolidate the immune-fluorescence results, we compared the H3K27me3 between different type embryos by western-blot (response Fig. 6E, F ; the revised version Fig 3C; Appendix Fig S3E) . In the first set of experiments, SCNT-tdTomato + , SCNTtdTomato -and ICS-embryos were collected at 2-cell stage, the numbers of the embryos harvested for WB are 500, respectively. Furthermore, the polar bodies were also removed to avoid histone contamination. As immune-fluorescence results, only in short-exposure condition, the H3K27me3 modification was effectively detected in the in the SCNT-tdTomato-and cumulus cell. When the embryos used for the WB were increased to 1,000 and under long-exposure condition, a weak band against theH3K27me3 was detected in the SCNT-tdTomato + and ICSI samples. Therefore, the H3K27me3 modification in the SCNT-tdTomato + and ICSI 2-cell embryos is present at very low levels, but it can be detected. Even after these changes, all the results were consistent with our previous conclusions: the modification of H3K27me3 is higher in SCNT-tdTomat -groups than SCNT-tdTomato + and ICSI groups. Referee #2 also pointed out the similar problem, we are so sorry for our inappropriate description in the text and for the confusion cause by this. We have carefully checked and revised the inappropriate statements in the original manuscript, and rewrote several sentences to avoid the overstatement about the mechanistic/causal relationships. Nevertheless, the H3K27me3 modifications are striking contrast to H3K9me3 and H3K4me3, there were dramatic changes in H3K27me3 during early development in both ICSI and SCNT embryos. 
A B C D E F
Thanks for this advice. We re-performed all the immune-fluorescence assay. According your suggestion, these images are projected of 10 sections from a confocal z-series, and the series section images also presented in the revised manuscript (response Fig 7A, B ; the revised version Fig 3D; Appendix Fig S3G) . These results consistent with our original manuscript and previous reports [22] (PMID: 15766761). Figure 3D . H3K27me3 staining now clearly appears in the 4-cell stage with no apparent difference between Tomato-and + groups. This is apparently at odds with the dramatic difference between these two groups at the 2-cell stage. How do the authors explain this dramatic change from the 2-cell to 4-cell stage?
Response 9:
As the reviewer points out, we have also noticed this phenomenon. [24] (PMID: 26359639). These observations described here suggest H3K27me3 may have a new role to defining ZGA related genes expression, and KDM6A/B may be a temporally regulated ZGA event. Our and other studies have shown that the H3K27me3 exists an "erase and rebuild" pattern in preimplantation embryos, this dynamic reconstruction process must be related to the catalytic enzyme [25] (PMID: 19602512). Although H3K27me3 demethylases KDM6A and KDM6B have been identified, the mechanism by which enzymes are targeted to specific genomic regions to remove H3K27me3 marks has not been established. Indeed, we are doing further research on this hypothesis.
7
A B
Comment 10: *In addition the difference the authors report at the morula stage is not well-founded as the image presented for the Tomato-group is not in fact a morula, as it contains significantly more cells than the other groups. It is essential to compare similar stages of development.
Response 10:
Thanks for your reminding, we have corrected it (in the revised manuscript Fig 3F) .
Comment 11: * Figure 3F . Is this method of quantification a fair representation of the data? Dividing embryos into positive and negative groups necessitates a clear bimodal pattern of staining between negative and positive groups. Can the authors show that this is indeed the case? Otherwise a quantification of average fluorescence intensity in nuclei is required.
Response 11:
According your valuable suggestion. For the statistical results, we re-calculated all the experimental data, and modified the figure legends to improve clarity by adding information regarding the experimental approach and a description of the figures. In addition, the numbers of experimental replicates and embryos used in the assays have been included. For fluorescence quantification, the signal intensity was analyzed as described previously [26] [27] [28] (PMID: 18784248, 20422712, 25925669). Briefly, nuclei of blastomeres were identified by DAPI staining. Quantification analysis of fluorescence intensity in nuclei or cytoplasmic areas was performed using ImageJ software (NIH, Bethesda, MD, USA; http://rsbweb.nih.gov/ij/). In addition, at least three different cytoplasmic areas were delineated for normalization to background. The average pixel intensity of the nuclear areas was calculated by ImageJ, and then normalized by dividing by the average pixel intensity of the background areas. Detailed description about our quantification methodology has been provided in the Materials and methods section of the revised manuscript. We re-typed the order in revised manuscript Fig 3, and added the result of data.
Comment 12: Figure 4 appears sound scientifically, although the presentation needs improvement. What is being shown in Figure 4C ? Is it a digestion of the vector? Or an RNA gel of the transcribed product? The text needs improvement also, as for example page 8, line 183; 'the KDM6A and KDM6B expression vectors specifically demethylate H3K27me3'. The vectors do not demethylate. Page 7, line 177 the HA tag is in the wrong orientation -it should be KDM6A-HA for a C-terminal tag. Perhaps the title of Figure 4 could be changed to include '...but not full-term development'.
Response 12:
We really appreciate your valuable suggestion. We reviewed every figure citation carefully in the revised manuscript (in the revised manuscript Fig 4C) . Adding more information regarding the experimental approach, and more description of the figures.
Comment 13 & 14: Figure 5 is also scientifically convincing. However it would be interesting to determine if the effect of KDM6B knockdown on embryonic development and later zygotic genome activation is dependent on the observed increase in levels of KDM6A as the authors suggest. *In this regard a double knockdown of both KDM6A and KDM6B should prevent the beneficial effects of KDM6B single knockdown.
Response 13 & 14:
In order to answer this interesting and important question, we designed and constructed siRNA specific target KDM6A. As we have shown that injection of siRNA-6A can specifically deplete KDM6A mRNA and protein. According your suggestions, we decrease the expression of KDM6A by injecting siRNA-6A into enucleated MII oocytes, and found that the SCNT blastocyst formation rate was significantly reduced (response Fig 8A, B ; the revised version Fig 5F, G; Appendix Table  S3 ). This phenotype is in agreement with our previous observation of injected KDM6B mRNA into SCNT embryos. To further examine whether the positive effect of siRNA-6B on SCNT embryonic development is dependent on the observed increase KDM6A expression. We further validated that double injection of siRNA-6A and siRNA-6B. We observed significantly lower developmental potential for siRNA-6A-6B double injected SCNT embryos, with the majority arresting at the 2-stage and only a few reaching the blastocyst stage. We next compared the ZGA related genes expression between different type siRNA injected SCNT embryos via RT-qPCR. Similarly, the qPCR results also showed that the expression of ZGA related genes are decreased in SCNT embryo with siRNA-6A or siRNA-6A-6B injected compared with the control (response Fig 8C; the revised version Fig 5H) . These results further demonstrate that the injection of siRNA-6B improve SCNT embryonic development, mainly through increased the expression of KDM6A. Error bars, s.e.m., n = 3. *P < 0.05, **P < 0.01, ***P < 0.001 according to two-tailed Student's ttest. n.s., not significant.
Comment 15:
Figure 5B The authors suggest that the optimal injection concentration was 10uM (page 9, line 217).
In Figure 5B it appears that the 20uM concentration is more efficient at reducing levels of KDM6B. What are the other reasons for the choice of 10uM? Is 20uM detrimental for development?
Response 15:
Yes, as the referee pointed out, the high injection concentration (20 µM) may be detrimental for embryo development. We agree that at 20 µM concentration, siRNA itself may have a negative effect on embryo development compared to uninjected embryos. This might in part be due to the toxicity of siRNA itself. This is a good question and was part of the original rationale for the serial dilution experiments. At the beginning of the knockdown assay, we noticed that the pluripotency genes Oct4, Sox2, and Nanog are acquire the H3K27me3 mark as they get repressed during ESCs differentiation [29] (PMID: 18371364). In addition, KDM6B also regulate the Hox gene expression, Yes, LINE-1 is not an ERV, we are so sorry for this mistake. It has been corrected now.
Comment 20: * Figure 7A , as for Figure 1E , the authors should also show absolute expression values without normalization to Gapdh. It is possible that Gapdh is also affected by KDM6B downregulation. Thanks for your reminding, we have corrected it.
Response to Referee #2: 【In order to conveniently answer your comments, we divide them in order.】 Yang et al. performed a following up study on investigating the role of H3K27me3 demethylases in mouse cloned embryos. They reported that the low efficiency of cloned embryos is due to the H3K27me3 reprogramming barrier. By manipulation of the level of demethylases of H3K27me3 (Overexpression of Kdm6a and knockdown of Kdm6b), the authors claim that they can improve the reprogramming efficiency. However, there are some major comments that I can't be convinced by this conclusion.
Major comments: Comment 1: Novelty: This study is mainly based on the authors' previous finding in Sci Reports (Yang et al., 2016) . The title of this manuscript is very similar to previous one. Also, the main hypothesis (compensation of Kdm6a and Kdm6b) is based on the previous finding. Therefore, the authors didn't characterise well enough their observation on the level of H3K27me3 in cloned embryos.
Response 1:
First of all, we thank for your time reviewing this manuscript and for your insightful comments. As you have pointed out, we have fully demonstrated our hypothesis (compensation of KDM6A and KDM6B) on Sci. Rep. [31] (PMID: 27384759), although it was carried out in the parthenogenetic embryos. According to your suggestion, we have also verified this hypothesis in SCNT embryos (please see response to the Comment 5 of referee #2). As for the similarity of the title, we just want to show our research has continuity. We also agreed that the initial title "H3K27me3 Demethylases KDM6A and KDM6B Play Contrasting Roles in Mouse Somatic Cell Nuclear Transfer" was a little similar to our previous paper, thus we would like to change the title to "Fine Tuning of Histone Demethylase KDM6A/B Improves the Development of Nuclear Transfer Embryo". Those confusions may be caused by our description of the result is not accurate in the previous version, where we re-described the result. We are so sorry for this improper description, and now it has been corrected in the text. In the revised manuscript, we have changed relate statement and moderated the claims in the manuscript, which we hope will be acceptable. For the H3K27me2 modifications. We performed new immune-fluorescence assay to detect the H3K27me2 modifications in different type embryos. As shown in response Fig 9 ( the revised version Appendix Fig S3D) , H3K27me2 modifications were detected in both kinds of embryos. 
Response 3:
We appreciate your insightful comment. Yes, as the referee pointed out. The H3K9me3 modification in SCNT 2-cell stage embryo was higher than ICSI embryos. In contrast, H3K4me3 was lower than ICSI groups (response Fig 10; the revised version Appendix Fig S3A) . Although both of them are differences, but compared with H3K27me3 modification, the different intensity/proportion of H3K9me3 and H3K4me3 modifications may weaken some. Recent a study has been shown that removing H3K9me3 enhances the development of SCNT embryos [32] , which may prove the correctness of our research from another aspect. In order to accurately display our results, we quantitatively analyzed the results of immunofluorescence (please see response to the Comment 11 of referee #1). We have carefully checked and revised the inappropriate statements in the original manuscript, and rewrote several sentences to avoid the overstatement about the mechanistic/causal relationships. Nevertheless, the H3K27me3 modifications are striking contrast to H3K9me3 and H3K4me3 in ICSI and SCNT embryos. 
Comment 4:
The number of scanned embryos is very low (n was less than 5) and there was no quantification. I suggest the authors should provide convincing statistical analyses on all of their key IF results (Fig2D, 3A 4E S3A S6D etc.). Otherwise, I am hesitating to believe those representative images.
Response 4:
Thanks a lot for this suggestion. In the original manuscript, our fluorescence statistics mainly came from two parts of the experimental data. One part comes from the fluorescence microscope and the other comes from confocal laser scanning microscope. Considering the preciseness and correctness, we only marked the confocal results. We also agree that the sample number wasn't large enough for several experiments. To improve these problems, we repeated almost all the experiments with an increased sample size, and quantified the data. We also modified the figure legends to improve clarity by adding information regarding the experimental approach. Furthermore, we re-calculated all the experimental data. In addition, the numbers of experimental replicates and embryos used in the assays have been included. For fluorescence quantification, the signal intensity was analyzed as described previously [26] [27] [28] (PMID: 18784248, 20422712, 25925669) . Briefly, nuclei of blastomeres were identified by DAPI staining. Quantification analysis of fluorescence intensity in nuclei or cytoplasmic areas was performed using ImageJ software (NIH, Bethesda, MD, USA; http://rsbweb.nih.gov/ij/). In addition, at least three different cytoplasmic areas were delineated for normalization to background. The average pixel intensity of the nuclear areas was calculated by ImageJ, and then normalized by dividing by the average pixel intensity of the background areas. Detailed description about our quantification methodology has been provided in the Materials and methods section of the revised manuscript. Detailed description about our quantification methodology has been provided in the Materials and methods section of the revised manuscript.
Comment 5:
Response 5:
Thanks for pointing out this key question! For the " Fig. 4D " in our previous Sci. Rep. [31] (PMID: 27384759) paper, "We did not observe any difference in H3K27me3 levels between the control embryos and the embryos injected with either KDM6A or KDM6B siRNA, but a marked increase H3K27me3 levels were observed when both siRNA injected". The premise of this phenomenon is that the embryo does not have H3K27me3 modifications at that stage. In other words, any single knock down KDM6A and KAM6B demethylase alone, unable to produce the H3K27me3 modification. We agree with your comments and helpful suggestion. In original version, we only verified our previous findings at the RNA levels. As you know, protein levels verification requires a lot of materials, and obtaining enough SCNT embryos is very challenging besides the experiments themselves. Note also that our experiments require enucleation, nuclear-injection and siRNA microinjections. After your reminding, we realized necessity and importance of the verification. In the revised manuscript, to further assess our previous Sci. Rep. paper reproducibility, we have performed an additional immune-fluorescence and immune-blot experiments for the SCNT embryos. As expected, we did not observe any difference in H3K27me3 levels between the control embryos and both injected with siRNA-6A-6B but a marked decrease H3K27me3 levels were observed when injected with either siRNA-6A or siRNA-6B (response Fig 11A, B ; the revised version Fig 5C; Appendix Fig S5C) . The western-blot result also confirmed this phenomenon at another protein levels (response Fig 11C, D; the revised version Fig 5B; Appendix Fig S5B) . These findings suggest that KDM6A and KDM6B are functionally redundant and compensate for each other in SCNT embryos; upon interference of either KDM6A or KDM6B, the levels of the other will increase. 
Response 6:
Typically, only 1~2% of mouse SCNT embryos can develop to term. In previous version, none of the SCNT control embryos developed to term under the same conditions. After our optimization, the birth rate of cloned mice reached 6%. Furthermore, we have also got six pairs of SCNT twins (as far as we know, previous studies have not been reported). Combined with the comments of Referee #3 about the X-chromosome in-/re-activation. In the revised manuscript, we have performed an additional SCNT embryo transfer assay, and only one (1.3%,1/77; in the revised manuscript Fig 7I, Appendix Table S4 ) Control-cloned mouse was obtained. 
Response 7:
In previous version, we have fully demonstrated that overexpression of KDM6A improved in vitro (dose-dependent) development of SCNT embryos, and knock-down of KDM6B improved development (in vitro and in vivo) of SCNT embryos. This is a good question and was part of the original rationale for the serial dilution experiments. At the beginning of the knockdown assay, we noticed that the pluripotency genes Oct4, Sox2, and Nanog are acquire the H3K27me3 mark as they get repressed during ESCs differentiation [29] (PMID: 18371364). In addition, KDM6B also regulate the Hox gene expression, which are essential for regulating cell differentiation and the formation of body structures during early embryonic development. [30] (PMID: 17713478). In order to avoid injuries caused by knockdown KDM6B, we chose the lowest but effective concentration of siRNA. The main reason for this confusion is that we have not clearly described the serial dilution experiments. In the revised manuscript, we have added new sentence to explained it.
Other minor comments 
Response 8:
We apologize for this careless mistake, and thank the reviewer for reading our manuscript carefully.
There are very few cloned embryos that can develop into blastocysts, and SCNT-tdTomato -only take few proportions. The most of SCNT-tdTomato + embryos can develop into blastocysts stage, but it is very difficult to display this phenomenon in 16 embryos. We replaced the inappropriate images/movie with new images/movie (response Fig 12; the revised version Fig 2B; Movies EV2 ). We hope this answers the reviewer's concern. 
Response 9:
The reviewer raised a very good point. As we have shown before, fine-tuning the expression of KDM6A and KDM6B can affect the expression of 2C genes, and which is dose dependent. At the present study, the concentration of siRNA mainly affects the 2-cell stage embryo. In blastocyst, with the continuous division of embryo, low concentration of siRNA has almost no effect. In our another independent and unpublished study, we found that the SCNT and ICSI blastocyst expressed "2-cell specific genes" at another suitable/appropriate concentration. Not only that, combined with our MERVL::tdTomato transgenic mice, we further found that fine-tuning the H3K27me3 modifications will expands cell fate potential in pluripotent stem cells. Relevant research is ongoing and some results have been achieved. It is conceivable that the molecular network mediating 2-cell specific genes expressing/silencing in preimplantation embryos is highly redundant.
Comment 10:
Line 89: why the reporter starts to express at the late 2-Cell stage?
Response 10: Thanks for this question. This confusion may be caused by our description and shown the live-cell image results. The result was now presented in the revised manuscript (response Fig 13A, B; the revised version Fig 1B; Appendix Fig S1C; Movies EV1) . The primary aim of present study is to establish a real-time monitoring system for ZGA events. Using this convenient system, we partially solved the problem of low development rate of cloned embryos. Furthermore, MERVL and other rodent ERV-L elements (MT2B, MT2C) together contributed the 5′ sequence to ZGA-related chimeric transcripts, and a recent study has shown that the chromatin surrounding MERVL is in a highly accessible state at the 2-cell stag [14] (PMID: 27309802). According to the present results, we only found the relationship between H3K27me3 and MERVL::tdTomato reporter in cloned embryos. Thanks for your suggestion. Fig 1C; Appendix Fig S1B) , MERVL::tdTomato and MERVL-gag were not detectably expressed in MII oocyte, which is consistent with a recent report [33] (PMID: 28323615). 
Response 12:
As you pointed out, we used MERVL::tdTomato transgenic mouse oocytes for ICSI, not for SCNT. Since the SCNT-embryos needs to be micromanipulation and cultured in vitro, we chose the ICSIembryos as a control. In addition, the development of ISCI-embryos is almost identical, which is beneficial to the detection of the MERVL::tdTomato reporter. If we use wild type oocytes (response Figure 15 upper panel) . For the ICSI, the sperm from MERVL::tdTomato transgenic mice were used as haploid nuclear donors. For the SCNT, the donor somatic cells are diploid. As you known, the transgenic copy number determines the reporter sensitivity. To resolve this problem, we designed the experiment as shown in response Figure 15 bottom panel. In this assay, the oocytes from MERVL::tdTomato transgenic mice were used as receptor for ICSI. Table S1 and Fig. 1G number doesn't match.
Response 13:
Thanks to carefully read our manuscript. In original version Fig 1G, the efficiency was calculated based on the number of 2-cell embryo. We have carefully checked and revised the figure legend to avoid this confusion (the revised version Fig 1I; Appendix Table S1 ).
Comment 14:
Is the concentration of CB 5mg/ml correct?
Response 14:
We are very sorry for this careless mistake. The CB concentration is 5µg/ml. Now these discrepancies have been corrected and the full text has been carefully revised.
Comment 15:
No text related to Fig. S5A and Fig. S7A -C.
Response 15:
Thanks for your reminding, we have corrected it.
Comment 16:
Incomplete of Reference such as Huang et al eLife.
Response 16:
References have been updated by EndNote software for EMBO reports style.
----------------------------------------------------------------------------------------------------------------
Response to Referee #3: 【In order to conveniently answer your comments, we divide them in order.】 Referee #3: Review of Yang, et al. EMBO Reports 2018. The authors are interested in understanding more about the differences between SCNT embryos and normal blastocysts. There has been prior work in this field, exploring the differences in transcription and chromatin factors, including some overlap with work present in this manuscript. However, our understanding is far from complete, and of high general interest -both for understanding this important early phase of development and for understanding how we might improve SCNT in mice and other mammals. The work is generally well designed and executed, and this paper has some novel work of interest, but the extent of novelty is not clear due to a recent publication by GY 2) A mouse with a MervL-tdTomato reporter is made, and SCNT blastocysts implant but don't develop after implantation.
3) SCNT embryos have more K27me3 than they should at 2-cell stage. 4) siRNA KD of KDM6B increases Kdm6A, and improves blastocyst formation and embryo birth rate. 5) Overexpression of KDM6A (but not KDM6b) improves preimplantation development, but postimplantation is still defective. 6) RNA-seq analysis shows that KDM6b KD is similar to fertilized embryos.
Major Issues: Comment 1: 1. I was not able to download and read the GY Bai et al., paper in Zygote (Dec 2017 online, Feb. 2018 published in print). The abstract indicates considerable overlap in the major claims. The editor should obtain this and consider the overlap, or relay to the reviewers for consideration.
Response 1:
Thank you for rising this question, that gives us this opportunity to make some clarification. Just from the Abstract section, you can easily find that our research is different from Bai et al.'s paper. As your clearness and conciseness summary, the results in the present study have six new discoveries. However, the paper published in Zygote only has one discovery, and we have doubts about their conclusion. Nevertheless, we cited Bai et al.'s paper in our revised manuscript, discussed their conclusions in the Discuss section, and softened the claim on the novelty of our study. For a further response, please refer to Cross-comments section. 
Response 2:
The reviewer raised a very good point. Combined with your Comment 6&7, we further studied the effect of fine-tuning KDM6A and KDM6B on X in-/re-activation in SCNT embryos. Please refer to Response 6&7 and Crosscomments section.
Comment 3: 3. Are the mouse lines with MERLV-tdTomato reporter isogenic? Do the authors know how many copies of the transgenes exist in the genome? These details should be included in the methods section.
Response 3:
Yes, as your point out. All the MERLV::tdTomato transgenic mice are syngeneic and bred by the same positive Founder (F0). All the embryos used in the experiment were produced by MERVL::tdTomato sperm and MII oocytes from the littermates of transgenic mice. The copy numbers of MERLV::tdTomato were detected by previously reported methods [34, 35] (PMID: 15985294; PMID: 17853944). In brief, we detected approximately 200 copies of MERLV::tdTomato in reporter transgenic mice as determined by quantitative PCR. Furthermore, the MERLV::tdTomato transgene copy number was stable throughout the F20 generations. According your suggestion, we have added these results in the materials and methods section.
Comment 4: 4. Are the SCNT-Mervl-tdTomato blastocysts that implant but don't survive actually parthenotes?
Response 4:
We deeply understand your concerns. First, the SCNT protocol we used is fully validated [36] (PMID: 17406224), and this protocol is written by Teruhiko Wakayama and Atsuo Ogura. Second, we used SCNT produced the first cloned mule [37] (PMID: 12775846). Third, the SCNT is carried in our outstanding micromanipulation center. Depend on SCNT technology, we have established a transgenic cattle/sheep production system [38] [39] [40] [41] [42] (PMID: 21918821, 22541322, 23623352, 25511933, 28158319). In this system, many surrogate cows/sheep can progress to early pregnancy, but only a few pregnancies develop to term. Most implanted SCNT embryos suffer growth retardation and are eventually absorbed by surrogate during pregnancy. To address these issues, we carry out related studies in mice. In order to answer your questions better, we revalidated our whole SCNT process, under the Hoechst 33342 staining (response Fig 16) . Representative images of the SCNT procedure. Left panel: hold the oocyte and cut the zona pellucida using piezo pulses (a, d). Just after aspirating (b) and releasing (c) the oocyte chromosomes. Insert the injection pipette into the enucleated oocyte (e). Apply a single piezo pulse to break the membrane, and inject the donor nucleus immediately (f). The white arrow indicates the oocyte chromosomes. The white arrow head indicates the nuclear donor cell. Right panel: before and after enucleation of oocytes.
Issues of interest that could be clarified: Comment 5: 1. What is the difference in domain structure between KDM6A and KDM6B? Is this effect dependent on catalytic effect? Could this be added to the discussion? Future experiments could test whether chimera proteins from KDM6A/B could identify the critical regions required for these effects.
Response 5:
As you pointed out, we are also interested in the structure of KDM6A and KDM6B. We have preliminary data regarding this specific comment. KDM6A and KDM6B are Jumonji (JmjC) domain containing proteins and catalyze the removal of trimethylation from histone H3K27 by using a hydroxylation reaction with iron (Fe 2+ ) and α-ketoglutarate (α-KG) as cofactors [43, 44] (PMID: 26564907, 20373914). The jumonji gene was named for a mutation in mice that causes abnormal cruciform neural grooves (in Japanese, jumonji means cruciform). As shown in response Fig 17A  (in the revised manuscript Fig 4J) , KDM6B shows high homology and structural relationship to KDM6A, especially in the JmjC domain, but lacks the tetratricopeptide (TPR) domain, which are assumed to mediate protein-protein interactions [45, 46] (PMID: 10517866, 21153002) . In order to further compare the differences between KDM6A and KDM6B in SCNT reprogramming. We synthesized KDM6A-HA expression vectors with different loci mutation, and injecting different type KDM6A-HA mRNA into SCNT embryos. When KDM6A-cM-HA (JmjC domain mutant) or KDM6A-ncM-HA (TPR and JmjC domain mutant) was ectopically expressed in embryos, no reduction in H3K27me3 methylation levels was observed (response Fig 17B, C; in the revised manuscript Fig 4D; Appendix Fig S4D) , which demonstrating that the demethylation activity is dependent on JmjC domain. Furthermore, the blastocyst formation rate of SCNT embryos was greatly reduced when KDM6A-nM-HA was injected, which was similar to that of KDM6B injected SCNT embryos (response Fig 17D, E; in the revised manuscript Fig 4F, K; Appendix Table S2 ). Compared with the control group, the efficiency of SCNT was no different by injecting KDM6A-cM or KDM6A-cnM-HA into SCNT embryos. These results suggesting that the TPR and JmjC domain were required for KDM6A rescue the poor developmental phenotype of SCNT embryos, and indirectly indicate that TPR domain may mediate protein-protein interactions for moderate KDM6A activity in the SCNT reprogramming. 
Response 6 & 7:
We agree with the reviewers' comments and appreciate the suggestion offered by the reviewers. The one aim of this study is generating a transgenic report mice for real-time monitoring ZGA events.
Utilize this system, we only solve one of the many SCNT problems. As we mentioned in the Discussion, there are many obstacles in the process of converting somatic cells into pluri-/toti-potent cells, which obstacle is the core? More analyses are needed on this issue. In this study, we only want to solve the ZGA event in the SCNT embryos. It should be noted that X-inactivation and ZGA are occurring at different stage. As your pointed out, the X chromosome inactivation is another important thing for mammalian embryo development. In the mouse, X-inactivation is first detected at the late morula/blastocyst stages, and the extraembryonic lineages in which paternal X chromosome is selectively inactivated. The random inactivation of the paternal X or maternal X occurs later in the embryonic ectoderm lineage, and this pattern is maintained in adult somatic tissues. Consistent with a role in the initiation of inactivation, the Xist (long non-coding RNA, lncRNA), transcripts are first detected in mouse embryos before functional X-inactivation at the 4-cell stage and exclusively from paternal X (imprint Xi). But we think functional characterization of KDM6A/B and X-inactivation is not our primary aim and is out of the scope of this study. However, through your reminding, we read and analyzed the GY Bai et al., paper in Zygote. We disagree with their claims. Therefore, we made additional experiments. Please refer to Cross-comments section.
Response to Cross-comments: Cross-comments from referee 2: Since all 3 reviewers and editor consider the novelty of this manuscript could be an issue, I believe most of the future reads will think about the same thing. The MERLV reporter mice will be very useful but I agree with referee 3's point that more information needs to be provided.
Response:
We agree with the referee's comment that the publication time of this study will be later than Bai et al., paper in Zygote. We admit that novelty is important for scientific research, but it is inappropriate to judge novelty by publishing time. We believe that the novelty could be illuminating new research area, creating new methodologies, and experiments integrity and continuity. Although we and Bai et al. all studying the SCNT reprogramming, but the starting point (ZGA vs. X-inactivation) and conclusion are completely different. It should be noted that X-inactivation and ZGA (zygote genome activation) are occurring at different embryonic stage (Xist, 4-cell stage; functional X inactivation, morula/blastocyst; ZGA, 2-cell stage). Here, we need to re-emphasize the novelty of our study, as the Referee #3's summary: In a series of rigorous experiments, we demonstrated that only injection with a low concentration (20 or 50 ng/µl) of KDM6A mRNA could facilitate the cloned embryos ZGA, and improve the preimplantation developmental potential. Although we were able to efficiently obtain SCNT blastocysts by KDM6A (20 or 50 ng/µl) injection, but failed to obtain live cloned pups. In recently, one study claimed that injection with a higher concentration (1,000 ng/µl) of KDM6A mRNA can improve the SCNT embryo preimplantation development [47] (PMID: 29239295), which were contrary to present study. Furthermore, Bai et al. only found high efficiency in preimplantation development of SCNT embryos by reducing H3K27me3, but whether the post-implantation development of SCNT embryos can also be improved is not test. In addition to abnormal ZGA, another SCNT reprogramming barrier is aberrant Xist activation following SCNT [48, 49] (PMID: 16007070, 30033120). The downregulation of X-linked genes is mainly caused by the ectopic expression the Xist, which responsible for the X chromosome inactivation (XCI). Deletion of Xist or repression of Xist expression by siRNA can elevate about 10-fold normal birth rate of mouse cloning [50, 51] (PMID: 20847234, 22065773). Bai et al. claimed that H3K27me3 removal also corrected SCNTspecific aberrant XCI status in cloned embryos. This was especially of interest since it was previously reported that H3K27me3 serves as the imprinting mark of Xist, and loss of H3K27me3 induces Xist ectopic expression [52] (PMID: 29089420). To further determine the role of KDM6A in the XCI of SCNT, we injected KDM6A mRNA (1,000 ng/µl) into SCNT embryos, and found that the developmental efficiency of SCNT embryos was reduced, while many X-linked genes were consistently repressed. In contrast, knockdown of KDM6B could increase the SCNT embryo birth rate as well as the efficiency of DMD-specific NT-ESC derivation. Thus, knock down KDM6B not only facilitate the cloned embryos ZGA, but it can also impede ectopic Xist expression in SCNT reprogramming. In the Zygote paper, Bai et al. claim that overexpression KDM6A correct the Xinactivation errors of cloned embryos. However, we cannot find this phenomenon from their current results. In contrast, recent an unbiased study in normal embryos demonstrated that overexpression of H3K27me3 demethylase will lead to more serious X-inactivation errors [52] (PMID: 29089420). Thus, Bai et al.'s hypothesis has some problems. Furthermore, Atsuo Ogura's lab have been fully demonstrated that the repairing X-inactivation errors have no effect on the development of cloned mouse embryos during pre-implantation stages [51] (PMID: 22065773). In other words, correct the aberrant X-inactivation status of cloned embryos could not increase the rate of SCNT blastocyst formation. Although our present study mainly focus on ZGA event rather than X re-/in-activation, functional characterization of these newly finding is not the primary aim and out of this study scope.
To ensure the scientificity and authenticity of our study, we designed additional experiments to further prove our hypothesis. Combined with the comments of Referee# 3, We added a new content in the revised manuscript. The new contents are as follows:
Knockdown KDM6B not Only Facilitate ZGA in SCNT, but also Impede Ectopic Xist Expression The results above showed that 2-cell stage aberrant epigenetic reprogramming can be rescued through overexpression KDM6A or knock down KDM6B. Although aberrant SCNT-ZGA is believed to the main reason for low cloning efficiency. Another error identified in SCNT embryo is ectopic expression of the Xist (X-inactive specific transcript), which initiates X chromosome inactivation. Recently, H3K27me3 was identified as an imprinting mark for Xist [52] (PMID: 29089420), which prompted us to ask whether it is also responsible for fine-tuning KDM6A/B improved development of SCNT embryo. Due to exact adjustment by siRNA is technically difficult, we next primarily focused on male SCNT embryos with only a single X chromosome and never expressed at 4-cell stage. According to a previous report [53] (PMID: 8410812), sex screening of early mouse embryos was determined by PCR using a single blastomere biopsy at the 4-cell stage (response Fig 18A; in the revised manuscript Fig 7F) . To determine whether loss of H3K27me3 modification can induce Xist derepression in embryos, we first injected KDM6A and KDM6B mRNA into ICSI derived embryos. As Inoue A et al. report [52] (PMID: 29089420), RNA fluorescent in situ hybridization (FISH) analysis confirmed that KDM6A/B mRNA injection induce ectopic expression of Xist, and only KDM6A in a concentration-dependent manner (response Fig  18B; in the revised manuscript Appendix Fig S7F) . To evaluate the effect of fine-tuning KDM6A/B on Xist expression in SCNT embryos, we harvested Sertoli cell derived SCNT embryos for Xist RNA detection via FISH assay. As shown in response Fig 18C (in the revised manuscript Fig 7G) , the majority of SCNT derived blastomere showed Xist RNA signal, and ICSI derived embryos showed no Xist signal. As expected, KDM6B knockdown by siRNA-6B led to Xist down-regulation and loss of Xist signal within the nucleus of SCNT embryos. In contrast, most of the siRNA-6A injected SCNT embryos still showed one strong Xist signal in blastomeres. Previous studies demonstrated that ectopic expression of Xist will lead to large-scale downregulation of X chromosome-linked genes in the SCNT embryos [50, 51] (PMID: 20847234; 22065773). The effect of siRNA-6B on ectopic Xist expression was further examined the expression levels of Xist and Xlinked genes (Tsix, Rnf12, Pgk1, Fmr1nb, Atrx, Uba1, Mecp2 and Plac1) via single embryo RTqPCR (response Fig 18D; in the revised manuscript Fig 7H) . Consistent with the FISH results, the significant down-regulation of Xist observed in SCNT embryos that had been injected with siRNA-6B. In contrast, Xist was significantly up-regulated in KDM6A mRNA injected SCNT embryos, and the X-linked genes were also up-regulated in siRNA-6B injected embryos.
Previous studies have demonstrated that the ectopic expression of Xist in SCNT derived embryos could be corrected by siRNA-Xist, leading to more than a 10-fold increase in the birth rate of male clones [50, 51] (PMID: 20847234; 22065773). To examine whether the combination of siRNA-Xist and siRNA-6B could further improve SCNT embryonic full-term development. We then performed embryo transfer experiments to assess the full-term developmental ability of siRNA-Xist-6B coinjected SCNT embryos. Similar to previous report [51] (PMID: 22065773), injected with siRNAXist alone improved the birth rate from 1.3% (1/77) to 11.7% (12/103) (response Fig 18E; in the revised manuscript Fig 7I; Appendix Table S4 ). Importantly, siRNA-Xist-6B coinjected further increased the SCNT birth rate to 21.1% (16/76 ). This result indicates that siRNA-6B and siRNAXist exert a synergistic effect on the SCNT reprogramming. Thus, knock down KDM6B not only facilitate the cloned embryos ZGA, but it can also impede ectopic Xist expression in SCNT reprogramming. Cross-comments from referee 1: A more in depth characterisation of the reporter strain to show that it does indeed fully recapitulate the endogenous MERVL expression pattern throughout preimplantation development is necessary (RE comments to Figures 1+2) . As I mention in my review I believe that this manuscript potentially significantly extends on previous studies, and thus the novelty is not a major concern, as long as the major comments are addressed. In particular there are concerns about the H3K27me3 immunostaining experiments also from Reviewer 2.
We thank the reviewer for supporting publication of the manuscript. We have amended the text accordingly. We would like to express our gratitude for all the profound comments from Referee #1.
Thank you for the submission of your revised manuscript. We have now received the comments from the referees, and I am happy to tell you that all support its acceptance now.
Referee 1 suggests to change the focus and may be the title of the manuscript to stress the usefulness of the MERVL reporter lines for the field. While referee 3 agrees that these lines will be useful, s/he also notes that the "heart" of the study are the differential roles of Kdm6a versus Kdm6b in SCNT. I therefore think that both aspects should be stressed. I also think that the major issue of referee 3 does not need to be addressed experimentally, but if you have these data please include them.
A few other changes are also needed:
-Please add scale bars to Fig 1D, Fig S1B, S4C , S6B, S6G.
-The figure panels are not always called out in the right order, some panel call outs are missing, and some are not correctly called out, please correct. Eg "Movies EV1" should be "Movie EV1", "Dataset EV1, 2" should be "Dataset EV1 and EV2".
-The panels do not follow their alphabetical order in some of the figures, please amend. Each figure needs to fit on one page.
-For Figs 2D, 4I, 6G and S6C please specify the number "n" of independently performed experiments. If the data are based on a single experiment (single mother) only, please remove the statistics.
-Please explain in the 3 Datasets what the first row is (C1, D1, etc)
-The legends for Figs S1D, S3E and S5B note that uncropped western blots are shown, but the bands are clearly pasted in onto a similar background color. Please send us the source data (full gels) for all bands shown in these figures and clearly mark the bands that are cut out as such. Control bands must be run on the same gels as the bands of interest.
-Please upload all movies together with their legends in zipped files. Please upload one file per movie plus legend.
-EMBO press papers are accompanied online by A) a short (1-2 sentences) summary of the findings and their significance, B) 2-3 bullet points highlighting key results and C) a synopsis image that is 550x200-400 pixels large (the height is variable). You can either show a model or key data in the synopsis image. Please note that text needs to be readable at the final size. Please send us this information along with the revised manuscript.
I look forward to seeing a final version of your manuscript as soon as possible. Please let me know if you have any comments or questions.
REFEREE REPORTS
Referee #1:
The authors have gone to considerable lengths to answer the comments raised in the first round of revision. Overall they have addressed the concerns suitably. Notably they have now demonstrated by a variety of techniques the expression pattern of the MERVL reporter strain successfully recapitulates the endogenous expression pattern. In addition they have addressed the inconsistency with previous reports in relation to H3K27me3 levels in the embryo. However they should check carefully the labelling of Figures and Legends throughout as I have noticed two mistakes in Figure  3C and Figure 3F in labelling Tomato+ vs Tomato-. The double knockdown of KDM6a and 6b also shows the expected results fitting with their model. Overall I recommend publication of this manuscript. My opinion on the novelty is the same as previously. As a suggestion (and if it is not too late already) I would consider changing the emphasis and perhaps the title of the manuscript to reflect what is in my view the most important aspect of this work, which is the MERVL reporter and its application to identify potentially successful embryos (either from ICSI or SCNT).
Referee #2:
The authors have provided a revised manuscript that addressed the reviewer's comments and concerns. The additional data and control experiments now substantially strengthen the paper. The reviewer is supportive of the publication of this manuscript in EMBO R.
Referee #3:
Review of EMBO Reports Yang et al., EMBOR-2018-46240V2
The authors are addressing a key issue in early developmental biology, and more specifically of interest to those pursuing animal cloning -the identification of factors than can make SCNT more efficient, and the role of Xist. Prior work has demonstrated that SCNT in most mammals is very inefficient, and prior work has claimed improvements through the introduction of histone demethylases in the KDM6 family, which were shown to alter H3K27me levels in SCNT embryos (e.g. Bai et al., Zygote 2018 (2017 online). There is also new work from the Zhang lab on Kdm4d, and the use of Xist KO cells, to improve SCNT. Thus, there is considerable published and active work in this area.
The work begins with the construction of a transgenic mouse with the MERVL::tdTomato, which reports proper ZGA execution followed by validation studies on a panel of known ZGA genes. Interestingly (though expectedly) SCNT embryos show poor ZGA execution relative to ICSI embryos, and Tomato-embryos showed poor progression and no implantation. The authors then show misregulation/localization of key transcription factors such as Nanog and Cdx2 in Tomatoembryos. Overall, these sections are well executed.
Next, the authors examine histone modifications in cloned and ICSI embryos, and show a selective change in H3K27me3, but not H3K27me2 (or H3K9me3 or H3K4me3), and further examined the temporal and localization aspects of H3K27me3. I found this interesting. The heart of the work is the demonstration that Kdm6a, but not Kdm6b, is effective at improving blastocyst formation and embryo retrieval at E8.5 in SCNT embryos -although both are capable of similar reductions in H3K27me3. Unfortunately, Kdm6a fetuses ultimately failed, and were readsorbed after E8.5.
The work has some additional structure function analysis on KDM6a. Knockdown studies show that Kdm6b knockdown (which was previously shown to increase Kdm6a expression) promoted progression to blastocyst. Of interest, Kdm6b knockdown allowed a low percentage (6%) of embryos to progress to term, and allowed for more efficient derivation of ntES lines. Of particular interest, knockdown of Kdm6b altered the transcriptome of SCNT embryos to better resemble those of fertilized embryos, and allowed for expression of ZGA genes such as Zscan4. Furthermore, the combined MERVL::tdTomato and Oct4::EGFP mouse could be a valuable reagent for future studies of ZGA and lineage programming.
Finally, there are a set of interesting experiments on the relationship between Kdm6a/b, Xist expression, and X chromosome gene expression. The affect here with Kdm6b knockdown is intriguing, as is the difference with Kdm6a.
Overall, this is a well executed set of experiments with some interesting results. There is prior work that does affect the novelty of the current paper, especially the Bai et al., Zygote paper. In my view, this is offset by the rigor and depth of the current study, which gets us closer to the mechanism and shows an interesting interplay between Kdm6a and Kdm6b, which is not developed in the Bai et al., study. There is also the generation of useful mouse lines. Therefore, I think the work is borderline, but could be considered appropriate for EMBO Reports.
Major issue: I am curious whether there is a difference in the efficiency of recruitment of Kdm6a versus Kdm6b to the Xist locus. Testing this would help provide a mechanism for the very different observations with Xist.
Minor issues:
There are grammar issues in certain sections -such as the latter sections of the results and some of the discussion. u Figures S1D, S3E , S5B need to label all bands and weight markers. As clearly bands were cut out, these need to be presented as cut out bands, with a white space around the cut gels, or a black frame, instead of pasting the pieces onto a similar background, which gives the impression that this is one gel. The figure legends need to explain what the two gel pieces are and how they were treated. In the revised manuscript, we have made every effort to ensure the correct call-out order.
u I would like to suggest a few changes to the abstract. Please check very carefully and let me know whether you agree with these: Despite the success of animal cloning by somatic cell nuclear transfer (SCNT) in many species, the method is limited by its low efficiency. After zygotic genome activation (ZGA) during mouse development, a large number of endogenous retroviruses (ERVs) are expressed, including the murine endogenous retrovirus-L (MuERVL/MERVL). In this study, we generate a series of MERVL-reporter mouse strains to detect the ZGA event in embryos. We show that the majority of SCNT embryos do not undergo ZGA, and H3K27me3 prevents SCNT reprogramming. Overexpression of the H3K27me3-specific demethylase KDM6A, but not of KDM6B, improves the efficiency of SCNT. Conversely, knockdown of KDM6B not only facilitates ZGA, but also impedes ectopic Xist expression in SCNT reprogramming. Furthermore, knockdown of KDM6B increases the rate of SCNT-derived embryonic stem cells from Duchenne muscular dystrophy embryos. These results not only provide insight into the mechanisms underlying failures of SCNT, but also may extend the applications of SCNT.
I also suggest a few changes to the short summary and bullet points: This study generates MERVL::tdTomato transgenic mice that monitor zygotic genome activation in real time, that show that H3K27me3 limits SCNT reprogramming, and that KDM6A overexpression or KDM6B knockdown improve the development of SCNT embryos.
• MERVL::tdTomato transgenic mice can be used to monitor ZGA events in real time.
• KDM6A and KDM6B functionally compensate each other in SCNT embryos.
• KDM6A overexpression or KDM6B knockdown improve the development of SCNT embryos. Ø Response: Sorry for the incorrect English. We agree with these changes, and we have changed the Abstract and Synopsis in the revised manuscript. We would like to express our gratitude for all the valuable and helpful suggestions from the editor.
